{
    "2021-01-22": [
        [
            {
                "time": "",
                "original_text": "医药股加速爆发，超九成公司预盈，板块投资前景如何？",
                "features": {
                    "keywords": [
                        "医药股",
                        "预盈",
                        "投资前景"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "疫情下的血制品板块——抓住供给下降带来的机会",
                "features": {
                    "keywords": [
                        "疫情",
                        "血制品",
                        "供给下降",
                        "机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "血制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业深度报告：后疫情时代 重磅疫苗品种批签大幅增长",
                "features": {
                    "keywords": [
                        "医药生物",
                        "后疫情时代",
                        "疫苗",
                        "批签增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "2020年血制品批签发跟踪：白蛋白进入提价窗口期",
                "features": {
                    "keywords": [
                        "2020年",
                        "血制品",
                        "批签发",
                        "白蛋白",
                        "提价窗口期"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "血制品",
                        "白蛋白"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}